# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Retinoic acid | 1 (Retinoic acid) | Imax | = | 70 | % | ALA3227241 | % | Homo sapiens | |||
2. | Retinoic acid | 1 (Retinoic acid) | IC50 | = | 0.15 | nM | ALA3227241 | 9.82 | nM | Homo sapiens | ||
3. | Retinoic acid | 1 (Retinoic acid) | Kd | = | 280 | nM | ALA3227240 | 6.55 | nM | Homo sapiens | ||
4. | ALA4802041 | EUB0001569 | qKD | 40 | uM | ALA4888332 | Not Active | uM | Homo sapiens | |||
5. | ALA4802042 | EUB0001568 | qKD | > | 75 | uM | ALA4888332 | Not Active | uM | Homo sapiens | ||
6. | Retinoic acid | 1 (Retinoic acid) | Efficacy | = | 80 | % | ALA3385312 | % | Homo sapiens | |||
7. | Retinoic acid | 1 (Retinoic acid) | pIC50 | = | 6.9 | ALA3385312 | 6.90 | nM | Homo sapiens | |||
8. | T0901317 | 2 | pIC50 | < | 5.3 | ALA3385312 | nM | Homo sapiens | ||||
9. | ALA3105681 | 8h | Efficacy | = | 100 | % | ALA3385312 | % | Homo sapiens | |||
10. | ALA3105681 | 8h | pIC50 | = | 7.2 | ALA3385312 | 7.20 | nM | Homo sapiens | |||
11. | ALA3105674 | 8a | pIC50 | < | 5.3 | ALA3385312 | nM | Homo sapiens | ||||
12. | Retinoic acid | 1 (Retinoic acid) | Efficacy | = | 35 | % | ALA3385308 | % | Homo sapiens | |||
13. | T0901317 | 2 | Efficacy | = | 55 | % | ALA3385308 | % | Homo sapiens | |||
14. | ALA3105681 | 8h | Efficacy | = | 87 | % | ALA3385308 | % | Homo sapiens | |||
15. | ALA3105674 | 8a | Efficacy | = | 40 | % | ALA3385308 | % | Homo sapiens | |||
16. | Retinoic acid | 1 (Retinoic acid) | pIC50 | = | 4.6 | ALA3385307 | 4.60 | nM | Homo sapiens | |||
17. | T0901317 | 2 | pIC50 | = | 5 | ALA3385307 | 5.00 | nM | Homo sapiens | |||
18. | ALA3105681 | 8h | IC50 | = | 64 | nM | ALA3385307 | 7.19 | nM | Homo sapiens | ||
19. | ALA3105681 | 8h | pIC50 | = | 7.1 | ALA3385307 | 7.10 | nM | Homo sapiens | |||
20. | ALA3105674 | 8a | pIC50 | = | 5.7 | ALA3385307 | 5.70 | nM | Homo sapiens |